Stay updated on Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.

Latest updates to the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page
- Check6 days agoChange DetectedRevision v3.4.3 added and revision v3.4.2 removed from the page history.SummaryDifference0.0%

- Check13 days agoChange DetectedVersion history now shows Contacts/Locations and Study Status in the record, reflecting up-to-date study metadata.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded Contacts/Locations and Study Status to the record history.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded Contacts/Locations and Study Status sections (Revision: v3.4.2) to the study history. Removed the government funding notice (Revision: v3.4.1).SummaryDifference0.5%

- Check41 days agoChange DetectedThe page now shows a government-funding lapse notice and updates the revision to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedGlossary display has been added, the page uses green highlights for additions and red highlights for deletions, and the 'No FEAR Act Data' label has been capitalized.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.